KOAN — Apollo Biowellness Balance Sheet
0.000.00%
- $0.38m
- $4.52m
- $1.90m
Annual balance sheet for Apollo Biowellness, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.114 | 0.013 | 0.064 | 0.007 | 0.008 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.055 | — | 0.15 | — | 0.056 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.169 | 0.27 | 0.375 | 0.977 | 1.03 |
Net Property, Plant And Equipment | — | 0.031 | 0.024 | 0.015 | 0.015 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 0.169 | 0.301 | 0.399 | 0.992 | 1.85 |
Payable / Accrued | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.17 | 4.4 | 1.55 | 3.13 | 5.05 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 1.17 | 4.4 | 1.55 | 3.13 | 5.05 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.996 | -4.1 | -1.15 | -2.14 | -3.2 |
Total Liabilities & Shareholders' Equity | 0.169 | 0.301 | 0.399 | 0.992 | 1.85 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |